Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, 7 Chung-Shan South Road, Taipei, Taiwan, 100,
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1375-84. doi: 10.1007/s00259-014-2692-z. Epub 2014 Feb 14.
Primary aldosteronism (PA), characterized by an excessive production of aldosterone, affects 5-13 % of patients with hypertension. Accurate strategies are needed for the timely diagnosis of PA to allow curability and prevention of excessive cardiovascular events and related damage. This study aimed to evaluate the usefulness of semiquantification of (131)I-6β-iodomethyl-norcholesterol (NP-59) single photon emission computed tomography (SPECT)/CT in differentiating aldosterone-producing adenoma (APA) from idiopathic adrenal hyperplasia (IAH) and in predicting clinical outcomes after adrenalectomy.
We retrospectively reviewed 49 PA patients who had undergone adrenalectomy after NP-59 SPECT/CT within 1 year. A conventional visual scale (VS) and two semiquantitative parameters generated from SPECT/CT, adrenal to liver ratio (ALR) and lesion to contralateral ratio of bilateral adrenal glands (CON), with cutoff values calculated by receiver-operating characteristic (ROC) analysis, were compared with pathology results and postsurgical outcomes to determine the accuracy.
An ALR cutoff of 1.84 and a CON cutoff of 1.15 showed an ability to distinguish adenoma from hyperplasia similar to VS (p = 0.2592 and 0.1908, respectively). An ALR cutoff of 2.28 and a CON cutoff of 1.11 yielded the highest sensitivity and specificity to predict postsurgical outcomes, and an ALR of 2.28 had an ability superior to VS (p = 0.0215), while a CON of 1.11 did not (p = 0.1015). Patients with either ALR or CON greater than the cutoff had a high probability of positive postsurgical outcomes (n = 36/38), while patients with both ALR and CON less than the cutoff had a low probability of positive postsurgical outcomes (n = 2/11).
Semiquantification of NP-59 scintigraphy has an ability similar to VS in differentiating APA from IAH, but an excellent ability to predict postsurgical outcomes of adrenalectomy. An ALR or CON greater than the cutoff strongly suggests benefits from adrenalectomy, and both ALR and CON less than the cutoff implies a reduced chance of improvement in postsurgical outcome.
原发性醛固酮增多症(PA)的特征是醛固酮过度产生,影响 5-13%的高血压患者。需要准确的策略来及时诊断 PA,以实现可治愈性并预防过度的心血管事件和相关损害。本研究旨在评估 131I-6β-碘甲基去甲胆固醇(NP-59)单光子发射计算机断层扫描(SPECT)/CT 半定量在鉴别醛固酮瘤(APA)与特发性肾上腺增生(IAH)以及预测肾上腺切除术后临床结果中的作用。
我们回顾性分析了 49 例在 NP-59 SPECT/CT 后 1 年内接受肾上腺切除术的 PA 患者。比较了常规视觉评分(VS)和 SPECT/CT 生成的两个半定量参数,即肾上腺与肝脏比值(ALR)和双侧肾上腺的病变与对侧比值(CON),通过受试者工作特征(ROC)分析计算出截断值,并与病理结果和术后结果进行比较,以确定准确性。
ALR 截断值为 1.84,CON 截断值为 1.15,在区分腺瘤与增生方面与 VS 相似(p=0.2592 和 0.1908)。ALR 截断值为 2.28,CON 截断值为 1.11 可获得预测术后结果的最高敏感性和特异性,ALR 2.28 的能力优于 VS(p=0.0215),而 CON 1.11 则不然(p=0.1015)。ALR 或 CON 大于截断值的患者术后结果阳性的可能性较高(n=36/38),而 ALR 和 CON 均小于截断值的患者术后结果阳性的可能性较低(n=2/11)。
NP-59 闪烁显像的半定量在区分 APA 与 IAH 方面与 VS 相似,但具有极好的预测肾上腺切除术术后结果的能力。ALR 或 CON 大于截断值强烈提示肾上腺切除术有益,而 ALR 和 CON 均小于截断值则意味着术后结果改善的机会降低。